Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Passage BIO, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 45 | +1 |
| Shares | 40.3M | 817.5K | 38.7M | −792.8K (−2.0%) |
| Value | $32.0M | $649.3K | $27.1M | −$4.28M (−13.7%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Passage BIO, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 721,735 | $505.2K | 0.00% |
| Shay Capital LLC | 92,256 | $64.6K | 0.02% |
| Landscape Capital Management, L.L.C. | 53,915 | $37.7K | 0.00% |
| Engineers Gate Manager LP | 34,770 | $24.3K | 0.00% |
| Squarepoint Ops LLC | 27,927 | $19.5K | 0.00% |
| Two Sigma Securities, LLC | 21,635 | $15.1K | 0.00% |
| Jane Street Group, LLC | 12,271 | $8.59K | 0.00% |
| Nordwand Advisors, LLC | 2,500 | $1.75K | 0.00% |
| Advisor Group Holdings, Inc. | 1,770 | $1.24K | 0.00% |
| Northwestern Mutual Wealth Management Co | 64 | $45 | 0.00% |
Sold out (9)
Institutions that held Passage BIO, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Versant Venture Management, LLC | 4,026,417 | $3.20M |
| Acuitas Investments, LLC | 471,812 | $374.7K |
| Affinity Asset Advisors, LLC | 264,266 | $209.9K |
| Marquette Asset Management, LLC | 85,500 | $67.9K |
| Royal Bank of Canada | 693 | $1.00K |
| UBS Group AG | 1,146 | $910 |
| Rhumbline Advisers | 783 | $621 |
| Global Retirement Partners, LLC | 400 | $318 |
| Qube Research & Technologies Ltd | 4 | $4 |
Not filed for Q3 2024 yet (1)
Institutions that held Passage BIO, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 817,529 | $649.3K |